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ABSTRACT 
 
Stroke induces inflammation that can aggravate brain damage. This work examines 
whether interleukin-10 (IL-10) deficiency exacerbates inflammation and worsens the 
outcome of permanent middle cerebral artery occlusion. IL-10 and IL-10 receptor (IL-
10R) expression increased after ischemia. From day 4, reactive astrocytes showed strong 
IL-10R immunoreactivity. IL-10 KO mice kept in conventional housing showed more 
mortality after pMCAO than the WT. This effect was associated to the presence of signs 
of colitis in the IL-10 KO mice, suggesting that ongoing systemic inflammation was a 
confounding factor. In a pathogen-free environment, IL-10 deficiency slightly increased 
infarct volume and neurological deficits. Induction of pro-inflammatory molecules in the 
IL-10 KO brain was similar to that in the WT 6 hours post-ischemia, but was higher at day 
4, while differences decreased at day 7. IL-10 deficiency promoted the presence of more 
mature phagocytic cells in the ischemic tissue, and enhanced the expression of M2 
markers and the T cell inhibitory molecule CTLA- 4. These findings agree with a role of IL-
10 attenuating local inflammatory reactions, but do not support an essential function of 
IL-10 in lesion resolution. Up-regulation of alternative immunosuppressive molecules 
after brain ischemia can compensate, at least in part, the absence of IL-10.  
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INTRODUCTION 
 
Stroke induces inflammation that is considered detrimental in the acute phase. 
Insufficient oxygen supply triggers a transcriptional program designed to promote 
cellular adaptation to hypoxia 1,2. Ischemic conditions can induce the expression of 
inflammatory mediators in microglia 3,4, and up-regulate the expression of toll-like 
receptors (TLR) 5 and other danger signal receptors 6. Necrotic cell death induces 
secondary inflammatory reactions by liberating intracellular molecules to the 
extracellular environment 7 where they act as danger signals activating nearby glial cells. 
This process causes a second release of pro-inflammatory mediators 8 amplifying the 
initial inflammatory response to ischemia. Inflammatory mediators can be neurotoxic 9 
and they induce chemoattraction of blood leukocytes, which, in turn, can release 
proteases and pro-oxidant agents further exacerbating the lesion 10. However, the 
inflammatory reaction after acute brain damage is a complex dynamic process naturally 
set up to clear the necrotic tissue and evolving through various steps from initiation to 
resolution. Macrophages carry out an essential role in the process of tissue damage 
resolution by clearing dead cells and cell debris 11. Although numerous molecules have 
been identified as players in the multifaceted inflammatory response to acute brain 
damage, more knowledge is needed to understand the critical molecules orchestrating 
its dynamics. 
 
Interleukin-10 (IL-10) is a crucial anti-inflammatory cytokine that suppresses pro-
inflammatory signals and immune responses. Several lines of evidence support that the 
cerebral expression of IL-10 is beneficial after experimental stroke as IL-10 transgenic 
mice over-expressing IL-10 in astrocytes, microglia, and endothelial brain cells showed 
smaller infarcts 12. Furthermore, IL-10 gene transfer using adenoviral vectors reduced 
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infarct volume in a model of photothrombotic ischemia in rats 13. Accordingly, mice 
deficient in IL-10 showed larger infarctions after permanent middle cerebral artery 
occlusion (pMCAO) 14. In agreement with these findings, low levels of circulating IL-10 in 
patients with lacunar stroke were associated with a worse outcome 15. Animals deficient 
in IL-10 lack the anti-inflammatory drive of this cytokine, and therefore provide a good 
model to test whether and how IL-10 is involved in stroke outcome. Here we studied the 
inflammatory response of IL-10 knockout (IL-10 KO) mice to brain ischemia to better 
understand the role of this molecule in acute brain damage. 
 
METHODS 
 
Animals 
Animal work was carried out in agreement with the local regulations and in compliance 
with the Spanish Directives (Real Decreto 53/2013) that follow Directives of the 
European Community. Experimental procedures were approved by the Ethical 
Committee (CEEA) of the University of Barcelona (UB). IL-10 KO and wild type (WT) mice 
on a C57BL/10j background were obtained from the Jackson Laboratory. In an initial pilot 
study we found that some of the IL-10 KO mice kept under conventional animal house 
conditions developed signs of colitis. To avoid this pathology, IL-10 KO and WT mice were 
subjected to embryo transfer and were kept in a pathogen-free zone (SPF) in the animal 
house of the School of Medicine (UB). Under SPF conditions IL-10 KO mice did not 
develop overt signs of colitis at 3-4 months, in agreement with previous reports 16.  
 
Brain ischemia 
Permanent distal occlusion of the right middle cerebral artery (pMCAO) was carried out 
in adult (3-4 month) male WT (n=78) and IL-10 KO (n=68) mice under isoflurane 
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anaesthesia in 30 % O2 and 70 % N2O. After drilling a small hole in the cranium at the 
level of the distal portion of the MCA, the artery was occluded by cauterization. Flow 
obstruction was visually verified. Animals showing subdural haemorrhages or signs of 
incorrect surgery were immediately excluded from the study (less than 5 % in each 
group). After surgery, animals were allowed to recover from the anaesthesia and were 
returned to their cages.  
 
Infarct volume by MRI 
Infarct volume was assessed by MRI in a 7.0 T BioSpec 70/30 horizontal animal scanner 
(Bruker BioSpin, Ettlingen, Germany), equipped with a 12-cm inner diameter actively 
shielded gradient system (400 mT/m). The receiver coil was a phased array surface coil 
for mouse brain. Mice were placed in a supine position in a Plexiglas holder with a nose 
cone for administering anaesthesia (isoflurane in a mixure of 30% O2 and 70% N2O), fixed 
with a tooth bar, ear bars and adhesive tape and maintained under controlled 
temperature during the acquisition period. Tripilot scans were used for accurate 
positioning of the animal's head in the isocenter of the magnet. T2 relaxometry maps 
were acquired with a multi slice multi echo acquisition sequence with 16 effective echo 
times increasing from 11 to 176 ms, slice thickness= 0.5 mm, number of slices= 18, 
Repetition Time = 4764 ms, Field of view= 20 mm3, matrix size 256 pixels and spatial 
resolution 0.078 mm2/pixel. Data were processed using Paravision 5.0 software (Bruker). 
Infarct volume was calculated from the images using NIH Image-J software 
(http://rsb.info.nih.gov/ij). The area of infarction was measured in each brain slice and 
the total infarct volume was obtained by integration of the infarcted areas. A correction 
for edema was made in each area by multiplying the infarct area by the ratio of the 
contralateral to the ipsilateral hemisphere. Mice were scanned longitudinally at 1, 4 and 
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7 days, or only once before they were killed. Mice were assigned a code that did not 
reveal the identity of the groups and images were analyzed in a blind fashion.  
 
Measurements of infarct volume after tissue histology 
In a group of mice, infarct volume was determined by two methods, i.e. in vivo MRI at 
day 7 was followed by post-mortem histology in the same animals. After MRI, mice were 
anesthetized and transcardially perfused with saline followed by 4% paraformaldehyde. 
Brains were fixed overnight with this fixative, washed in phosphate buffer, cryoprotected 
in 30% sucrose and frozen. Serial coronal brain sections were obtained every 500 m in a 
cryostat. After cresyl violet staining, the area of infarction in each section was measured 
using Image-J software. Areas were integrated to calculate infarct volume. 
 
Assessment of brain edema 
The brain water content was measured 4 days after pMCAO using the wet/dry weight 
method. The cerebellum was excluded and the forebrain was divided in the two 
hemispheres (ipsilateral and contralateral). The two brain pieces were immediately 
weighed (wet weight), dehydrated at 65 ºC for 72 hours and reweighed (dry weight). The 
difference between wet and dry weight was normalized to the initial size of the tissue by 
dividing by the corresponding wet weight value. The ratio between the ipsilateral and 
contralateral water content was calculated and values are expressed as the percentage 
of increase in tissue water content induced by ischemia.  
 
Behavioural test 
At day 3, the adhesion/removal tape test that evaluates sensorimotor deficits was 
carried out as previously described 17. Briefly, an adhesive tape is placed in one of the 
forelimbs. The animal naturally tries to remove it and the time duration of the following 
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three steps is measured: time of forelimb shaking, time until contact with the mouth, 
and time until tape removal. Animals were trained the two days prior to ischemia.  
 
Microglia cultures 
Microglial cultures were obtained from the cerebral cortices of 1-day-old neonatal mice 
(Supplementary Materials) 8. Cells were subjected to ischemic conditions for 3 hours in 
an anoxia incubator (GalaxyR/RS Biotech, New Brunswick, Eppendorf, Enfield, CT, USA) 
containing an atmosphere of 95 % N2, and 5 % CO2 at 37 ºC, and they were kept for 3 
hours more under normoxic conditions. Other cells were exposed to 10 ng/mL 
lypopolysaccharide (LPS) (Escherichia coli 055:B5) (Sigma-Aldrich) for 6 hours. Ten ng/mL 
recombinant murine IL-10 (#210-10, PreproTech, Rocky Hill, NJ, USA) was added to the 
cell cultures 30 min before the above challenges.  
 
 qRT-PCR  
Total RNA was extracted using Purelink RNA Kit (Invitrogen, Spain). RNA quantity and 
purity were determined using ND-1000 micro-spectrophotometer (NanoDrop 
Technologies, Wilmington, DE, USA). One-μg total RNA was reverse-transcribed using a 
mixture of random primers (High Capacity cDNA Reverse Transcription kit, Applied 
Biosystems). TaqManR primer sequences were used to evaluate the expression of IL-10  
(Mm00439614_m1) and CTLA-4 (Mm00486849_m1) mRNA (Life Technologies). 
Quantification was carried out by normalizing Ct (Cycle threshold) values with Ct of the 
TaqManR primer sequence for glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
(Mm99999915_g1), and data were analyzed with the 2-CT method. The rest of PCR 
primers (see list in Supplementary Table 1) were designed with Primer3 software to 
bridge the exon–intron boundaries within the gene of interest to exclude amplification of 
contaminating genomic DNA. Primers were purchased from IDT (Laboratorios Conda 
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S.A., Torrejon de Ardoz, Spain). Real-time quantitative RT-PCR analysis was carried out by 
SYBR green I dye detection (#11761500, Invitrogen) using the iCycler iQTM Multicolor 
Real-Time Detection System (Bio-Rad, Hercules, CA, USA). Optimized thermal cycling 
conditions were: 1 min at 50 ºC, 8 min and 30 sec at 95 ºC and 40 cycles of 15 sec at 95 
ºC and 30 sec at 60 ºC. Data were collected after each cycle and were graphically 
displayed (iCycler iQTM Real-time Detection System Software, version 3.1, Bio-Rad). Melt 
curves were performed upon completion of the cycles to ensure specificity of the 
product amplification. Housekeeping gene for normalization was succinate 
dehydrogenase complex subunit A (SDHA). Quantification was carried out using the 
standard dilution calibration curve and values were normalized to the reference gene.  
For comparison purposes, values of all samples are expressed as fold versus the mean 
(n=3-6) control value. 
 
ELISA immunoassays 
The concentration of cytokines and chemokines in plasma was analyzed with Q-PlexTM 
Mouse Array IR assays (#130951MS, Quansys Bioscience, Logan, Utah, USA) and 
measures were obtained in an Odissey system (LI-COR, Lincoln, NE, USA). Conventional 
ELISA assays were carried out to measure the concentration of soluble IL-10 (#88-7104, 
eBioscience, San Diego, CA, USA) in brain tissue extracts that were obtained as described 
18. Tumor necrosis factor- (TNF-) (#88-7324-88, eBioscience) and IL-6 (#861.020.005, 
Diaclone, San Diego, CA, USA) were measured in the medium of cultured microglia.  
 
Isolation of cells from tissues  
Ischemic (4 days after pMCAO) (WT n=10 and IL-10 KO n=10) mice and controls (n=6 WT 
and n=6 IL-10 KO) were anesthetized and transcardially perfused with 40 mL saline. The 
ischemic parietal cortex (ipsilateral) and the corresponding cortex of the non-ischemic 
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hemisphere (contralateral) were dissected out and analysed separately. The dissected 
contralateral or ipsilateral regions of two mice were pooled together and incubated for 
30 minutes at 37°C in 5 mL of RPMI 1640 medium (Life Technologies S.A., Alcobendas, 
Madrid, Spain) containing 100 U/mL collagenase IV and 50 U/mL DNAse I, and pressed 
through a cell strainer (40 µm; BD Biosciences, San Jose, CA, USA). Cells were recovered 
after centrifugation at 400 xg for 10 min and separated from myelin and debris in 70 % 
and 30 % isotonic Percoll gradient (GE Healthcare) prepared in Hank's Balanced Salt 
Solution (HBSS) without calcium or magnesium. Samples were centrifuged at 1,000 x g 
for 30 min without acceleration or brake. Cells were collected from the interface, 
washed once with HBSS, and processed for flow cytometry.  
Spleens were obtained 4 and 7 days after pMCAO. They were dissected in 1 ml RPMI 
1640 medium and pressed through a 40 µm cell strainer (BD Biosciences). Cells were 
incubated for 5 min in red blood cell lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 0.1 mM 
EDTA) and washed twice in PBS.  
 
Flow cytometry  
Isolated brain cells were washed with fluorescence-activated cell sorting (FACS) buffer 
(phosphate-buffered saline, 2 mM EDTA, 2% FBS), incubated at 4 ºC for 10 min with 
FcBlock (1/200; Clone 2.4G2; BD Pharmingen), and incubated with primary antibodies in 
FACS buffer for 30 min at 4ºC. The antibodies used were rat anti-mouse CD11b (clone 
M1/70, Alexa Fluor 647, BD Pharmingen), CD45 (clone 30-F11, FITC, BD Pharmingen), 
F4/80 Pan macrophages (clone BM8, FITC, Hycult Biotec, Uden, The Netherlands), Ly6G 
(clone 1A8, PE-Cy7, BD Pharmingen). Isotype controls were rat IgG2bκ (clone A95-1, 
Alexa Fluor 647 or FITC, BD Pharmingen), rat IgG2a (FITC, Hycult Biotech), and rat IgG2aκ 
(clone R35-95, PE-Cy7, BD Pharmingen). Data acquisition was carried out in a BD 
FacsCantoII cytometer (BD Biosciences) using the FacsDiva software (BD Biosciences). 
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Cells were morphologically identified by linear forward scatter (FSC-A) and side scatter 
(SSC-A) parameters (Supplementary Fig. 1). Data analysis was performed with FlowJo 
software (version 7.6.5, TreeStar Inc., Ashland, OR, USA). Again, cells were plotted on 
forward versus side scatter and single cells were gated on FSC-A versus FSC-H linearity. 
Flow-Count Fluorospheres (Beckman-Coulter) were used for absolute quantification. 
 
Splenocytes were incubated in FACS buffer with FcBlock for 10 min at 4 ºC and then with 
the following antibodies for 30 min at 4 ºC: armenian hamster anti-mouse CD3 (clone 
145-2C11, Brilliant Violet-421, BioLegend), rat anti-mouse CD4 (clone GK1.5, FITC, 
AbDserotec), armenian hamster anti-mouse CD152 (clone UC10-4B9, PE, BioLegend), and 
rat anti-mouse CD25 (clone PC61, Alexa Fluor-647, AbDserotec). After surface staining, 
cells were prepared for intracellular staining by fixation for 20 min and permeabilization 
for 20 min. Fixation and permeabilization buffers were from eBioscience. Cells were then 
incubated for 30 min with rat anti-mouse Foxp3 (clone FJK-16s, PE-Cy7, eBioscience) 
antibodies. Isotype controls were Armenian hamster IgG (clone HTK888, Brilliant Violet 
421 or PE, BioLegend), rat IgG2bκ (clone A95-1, FITC or Alexa Fluor-647, BD Pharmingen), 
and rat IgG2aκ (clone R35-95, PE-Cy7, BD Pharmingen). Data were acquired and analyzed 
as indicated above. 
 
Immunofluorescence 
Cryostat brain sections (14 m-thick) were fixed with acetone, blocked with rabbit serum 
and incubated overnight at 4ºC with a rabbit polyclonal primary antibody against IL-10R 
(#C-20; Santa Cruz Biotechnology Inc., CA, USA) diluted 1:100. Then, sections were 
incubated for 2 hours at room temperature with a secondary anti-rabbit antibody (Alexa 
Fluor-488, Molecular Probes®). Double immunostaining was carried out with a mouse 
monoclonal antibody against GFAP conjugated with Alexa Fluor-546 (#8152, Cell 
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Signalling Technology, Danvers, MA, USA) diluted 1:50, or with biotin-conjugated tomato 
isolectin (#L0651, Sigma) followed by incubation with Alexa Fluor-546 streptavidin 
(#S11225, Molecular Probes®). Sections were counterstained with Hoechst to visualize 
the cell nuclei and they were observed under a confocal microscope (Leica SP5).  
 
Statistical analyses  
Statistics were carried out using GraphPad software (GraphPad Software Inc., La Jolla, 
CA, USA). One-way ANOVA was used for comparisons between multiple groups followed 
by the post-hoc Bonferroni test. Two-way ANOVA was used for comparisons by genotype 
and by either brain hemisphere (ipsilateral/contralateral) or by time. Linear regression 
analysis was used for correlation studies. Sample size for infarct volume measures was 
calculated taking into account the known SD of the researcher that carried out the 
ischemia model.  
 
RESULTS 
 
pMCAO induces the expression of IL-10 and IL-10 receptor in brain tissue of WT mice 
The expression of IL-10 mRNA progressively increased in the ipsilateral cortex of WT 
mice after pMCAO (Fig. 1A). The magnitude of IL-10 mRNA expression was positively 
correlated (p<0.03) to infarct volume, as assessed by MRI in the same animals, 6 hours 
(Fig 1B) and 7 days (Supplementary Fig. 2A) after pMCAO, suggesting that it was 
dependent on the severity of ischemia. A previous study showed that the numbers of 
cells expressing IL-10 mRNA in the ischemic tissue were correlated with the size of the 
lesion form 6 hours to 6 days after pMCAO in rats 19. The presence of soluble IL-10 
protein in the tissue also increased after ischemia, as assessed by ELISA (Fig. 1C). 
However, this parameter was not significantly correlated with infarct volume at day 4 
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(Supplementary Fig. 2B) showing some dissociation between the post-ischemic induction 
of IL-10 mRNA and the tissue concentration of IL-10.  
 
pMCAO also up-regulated the expression of IL-10 receptor (IL-10R) mRNA, but strong 
increases were not detected until day 4 (Fig. 1D). Immunofluorescence against IL-10R 
showed no immunoreactivity in the control cortex (Fig. 1E). One, 4 and 7 days post-
ischemia, IL-10R immunoreactive cells were occasionally seen in the subarachnoid space 
on the surface of the infarcted cortex (Fig. 1F, Supplementary Fig. 2C). However, it was 
not until day 4 that the expression of IL-10R was strongly up-regulated in reactive 
astrocytes of cortical layers I and II within the infarcted zone and at the subpial glia 
limitans (Fig. 1G,H). Isolectin positive myeloid cells immunoreactive for IL-10R were only 
occasionally detected (Fig. 1G). These results show that reactive astrocytes are strongly 
receptive to IL-10 and might be involved in modulating inflammatory and immune 
responses after stroke.  
 
IL-10 deficiency slightly increases lesion volume and neurological deficits after pMCAO 
Focal ischemia by distal pMCAO in C57 mice causes a lesion restricted to a portion of the 
cortical MCA territory (mainly the parietal cortex) (Fig. 2A). pMCAO did not cause 
mortality within the first 7 days, neither in WT mice nor in IL-10 deficient mice that were 
housed in SPF. However, in a preliminary experiment carried out in animals maintained 
under conventional housing conditions (not SPF) (WT n=9, IL-10 KO n=8) we observed no 
mortality in WT mice but 50 % mortality in the IL-10 KO mice within 7 days after pMCAO 
(Chi-square=5.88, p<0.05). IL-10 KO mice are known to spontaneously develop colitis 
when they are kept under conventional animal housing conditions 16. Post-stroke 
mortality in the IL-10 KO mice was associated to the presence of overt signs of colitis as 
assessed after visual observation of variable degrees of rectal prolapse, which 
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demonstrates a rather severe colitic condition. Furthermore, IL-10 KO mice housed in the 
conventional animal house had smaller (p<0.001) body weight (mean ± SD, n) (16.7 ± 3.1 
g, n=9) than the WT mice (27.5 ± 2.5 g, n=10) housed in the same conditions. This effect 
was not observed in IL-10 KO mice (27.8 ± 3 g, n=51) and WT mice (29.1 ± 3.8 g; n=45) 
housed in SPF. The finding that the presence of pathogens and ongoing peripheral 
inflammation in the IL-10 KO mice increased stroke mortality is in agreement with the 
notion that systemic inflammation aggravates stroke outcome 20. In order to explore the 
consequences of IL-10 deficiency in the stroked brain without confounding systemic 
inflammatory pathology, the following experiments were carried out after the mouse 
colonies (both IL-10 KO and WT mice) were transferred to a SPF environment. The 
concentration of pro-inflammatory cytokines in the plasma of IL-10 KO and WT mice 
(naïve and 6 hours after pMCAO) that were kept in SPF conditions was examined to 
verify the absence of signs of subclinical inflammatory pathology (Supplementary Fig. 3). 
 
The progression of brain damage was assessed in IL-10 KO and WT mice by carrying out a 
longitudinal MRI study at days 1, 4 and 7 after pMCAO using T2 relaxometry maps (Fig. 
2A). IL-10 deficiency increased the size of the MRI lesion, but group differences were 
small and they were at the limit of statistical significance (two-way ANOVA by genotype 
and time, p=0.049 for genotype effect, and p<0.001 for time effect) (Fig. 2B). The 
maximal infarct volume increase versus WT was 16 % at day 4. Notably, IL-10 deficiency 
did not impair the process of involution of the MRI lesion, since infarct volume decreased 
at day 7 in both WT and IL-10 KO mice (Fig. 2B). A successive reduction of infarct volume 
within the first two weeks after pMCAO has been previously reported in this 
experimental stroke mouse model 21,22. However, the histopathological and molecular 
correlates of lesion involution in this experimental pMCAO model in mice are not known. 
For histological validation of the MRI findings, we carried out ischemia in an additional 
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group of WT mice and IL-10 KO mice to evaluate infarct volume in vivo by MRI at day 7 
followed by histological evaluation in the same mice (Fig. 2C). The correlation between 
MRI infarct volume and the corresponding histology volume was very good (linear 
regression r2=0.8, p<0.001) (Fig. 2D). Two-way ANOVA by genotype and volume method 
(MRI versus histology) showed no significant effect of genotype but a significant effect of 
the volume method (p<0.001) due to smaller infarct volumes detected by histology (Fig. 
2E). This effect was attributable to post-mortem and post-processing brain volume 
changes and to larger errors when estimating the distance between sections after 
cryostat sectioning than after in vivo MRI, where slice thickness and distance between 
sections are precisely and automatically set. 
 
To assess whether the degree of edema within the first few days post-ischemia and the 
extent of shrinkage of the damaged tissue at later time points were different in the WT 
and IL-10 KO groups, we measured the ratio of the ipsilateral versus the contralateral 
MRI hemispheric brain volumes. At day 1, the volume of the ipsilateral hemisphere was 
larger than that of the contralateral hemisphere due to edema (Fig. 2F). This increase 
was attenuated at day 4, but at day 7 the volume of the ipsilateral hemisphere was 
smaller than that of the contralateral hemisphere due to tissue loss (Fig. 2A, F). However, 
these changes in brain volume were similar in the WT and IL-10 KO groups (Fig. 2F), 
suggesting that the absence of IL-10 interfered neither with ischemia-induced edema nor 
with lesion involution. In support of these findings, measures of brain water content at 
day 4 using the wet/dry weight method showed that ischemia increased the water 
content in the ipsilateral versus the contralateral hemisphere by (mean±SD) 0.98 ±0.27 % 
and 0.92± 0.37 % in WT (n=5) and IL-10 KO (n=2) groups, respectively.  
 
 15 
pMCAO induced only mild neurological deficits that could be detected by the 
adhesion/removal tape test, which evaluates sensorimotor alterations, but not by the 
neurological score tests 23 often used in models of transient intraluminal MCAO (not 
shown). The neurological deficit observed with the adhesion/removal tape test was 
greater in IL-10 KO mice than in WT mice. The test showed a worse performance of the 
contralateral forepaw (left) in IL-10 KO mice 3 days after pMCAO (Fig. 2 G-I). However, at 
day 7, the worsening effect of IL-10 deficiency was attenuated (Fig. 2 G-I), supporting 
that the effects of IL-10 were mainly manifested during the first days after stroke.  
 
IL-10 deficiency did not impair the cerebral inflammatory response early after pMCAO  
We examined the inflammatory response in brain tissue early (6 hours) after pMCAO by 
measuring the mRNA expression of several cytokines, chemokines, adhesion molecules, 
and other inflammatory molecules with qRT-PCR. In WT mice, ischemia induced the 
expression of cytokines, such as tumor necrosis factor- (TNF-), IL-1, and IL-6, as well 
as other inflammatory mediators, such as TLR-4, matrix metalloproteinase-9 (MMP-9), 
cyclooxygenase-2 (COX-2), and inducible nitric oxide synthase (iNOS) (Fig. 3). Ischemia 
also upregulated the mRNA expression of chemokines: monocyte chemoattractant 
protein-1 (MCP-1 or CCL2), neutrophil-activating protein KC (CXCL1), and macrophage 
inflammatory proteins MIP-1 (CCL3) and MIP-2 (CXCL2); the intercellular adhesion 
molecule-1 (ICAM-1); and growth factors, such as transforming growth factor- (TGF-), 
and insulin growth factor-1 (IGF-1) (Fig. 3). IL-10 deficiency showed a non-significant 
tendency to increase the expression of some of the above molecules in the ischemic 
tissue, while it induced a slightly lower expression of IL-6 and CXCL1 mRNA compared to 
that in WT mice (Fig. 3). Therefore, IL-10 deficiency did not significantly exacerbate the 
initial inflammatory reaction of resident cells within the first few hours following 
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pMCAO. The inflammatory reaction 24 to ischemia does not appear to be strongly 
regulated by IL-10 within the first hours after stroke onset. 
 
To examine the direct anti-inflammatory effect of IL-10 we carried out an in vitro study in 
primary cultures of murine microglia. Cultured microglia (Fig. 4) exposed to ischemic 
conditions showed increased expression of pro-inflammatory cytokines like TNF- (Fig. 
4A, G), IL-6 (Fig. 4C, I), and IL-1 (Fig. 4E) 6 hours later. Notably, treatment with 
recombinant IL-10 did not prevent this inflammatory reaction (Fig. 4A, C, E, G, I). In 
contrast, treatment with IL-10 strongly suppressed the inflammatory response of 
microglia stimulated with LPS (Fig. 4B, D, F, H, J), showing that IL-10 effectively blocked 
the response to stimuli inducing activation of TLR-4 but not to lack of oxygen.  
 
IL-10 deficiency induces an exaggerated inflammatory response 4 days after pMCAO 
In contrast to the findings 6 hours post-ischemia, at 4 days a significantly higher mRNA 
expression of TNF-, IL-1, IL-6, TLR-4, MMP-9, Cox-2, ICAM-1, MCP-1, CXCL1, and MIP-
1 was found in the ipsilateral cortex of IL-10 KO mice versus the WT  (Fig. 5). Also, 
expression of iNOS and MIP-2 mRNA tended to be higher in IL-10 KO mice, but 
differences were not statistically significant (Fig. 5). In contrast to the above increases, 
the expression of CX3CL1, which is mainly produced by neurons, was reduced in the 
ipsilateral cortex of IL-10 KO mice versus the WT (Fig. 5). In addition, small increases in 
several molecules (IL-1 and MCP-1 mRNA) were detected at day 4 in the contralateral 
cortex of IL-10 KO mice versus the WT (Fig. 5), suggesting that IL-10 might prevent 
secondary inflammation in remote brain regions too. The finding of more pronounced 
inflammatory responses in the IL-10 KO brain at day 4 after ischemia is in agreement 
with the observation that expression of IL-10 and IL-10R was strongly up-regulated at 
this time point (Fig. 1). 
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Differences in the inflammatory response of IL-10 KO and WT mice are reduced at day 7 
Differences between WT and IL-10 KO groups for the mRNA expression of several pro-
inflammatory molecules, such as TNF-, IL-1, IL-6, TLR-4, MCP-1 and MMP-9 (Fig. 6), 
were no longer statistically significant seven days post-ischemia. However, MIP-2 and 
Cox-2 mRNA was higher in the IL-10 KO mice than in the WT, and an increase in Cox-2 
expression also became apparent in the contralateral hemisphere compared with the 
corresponding WT (Fig. 6). At this time point, the mRNA expression of molecules 
involved in repair mechanisms 11, such as TGF- and IGF-1, had increased versus previous 
time points, but this effect was similar in WT and IL-10 KO mice (Fig. 6), indicating that 
resolution of inflammation progressed also in the absence of IL-10.  
 
Suppressive mechanisms are up-regulated in the IL-10 KO mice after pMCAO 
The numbers and features of myeloid cells found in brain tissue of IL-10 KO and WT mice 
were examined by flow cytometry 4 days after pMCAO. The relative proportion of cells 
corresponding to microglia (CD11bDimCD45low) decreased in the ischemic tissue of both 
IL-10 KO and WT mice compared to the contralateral hemisphere or the control brain 
(Supplementary Fig. 4). This effect was due to the presence of leukocytes (CD45High) in 
the ischemic brain (Supplementary Fig. 4). However, the numbers of leukocytes, both 
CD11b+CD45High (myeloid cells) and CD11b-CD45High (lymphocytes), were similar in IL-10 
KO and WT mice (Supplementary Fig. 4). Likewise, no differences in the number of 
F4/80+ cells (a marker of phagocytic microglia/macrophages) were found between the 
two genotypes (Fig. 7A). Nevertheless, IL-10 deficiency induced a shift in the phenotype 
of these cells due to the presence of significantly higher proportions and numbers of 
F4/80High cells in the ischemic tissue of IL-10 KO mice than in the WT, while this specific 
myeloid subpopulation was absent in the contralateral cortex or in controls (Fig. 7A). 
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F4/80High cells are considered mature macrophages undergoing terminal differentiation in 
the tissue microenvironment 25. Since F4/80High cells are phagocytic cells that are 
expected to actively participate in clearing the damaged tissue, we examined the 
expression of galectin-3, which in macrophages plays a critical role in phagocytosis. 
Higher galectin-3 mRNA expression was detected in the ischemic tissue of IL-10 KO mice 
(Fig. 7B), supporting that phagocytic activity was enhanced. Furthermore, the ischemia-
induced mRNA expression of typical anti-inflammatory M2 phenotype markers of 
myeloid cells, YM1 and arginase-1, was also significantly higher in the IL-10 KO mice (Fig. 
7B).  
 
Neutrophils (CD11b+Ly6G+) were detected in the ipsilateral cortex to a similar extent in 
IL-10 KO mice than in the WT (Fig. 7C). However, again the phenotype of these cells 
shifted in IL-10 KO mice since more Ly6GHigh cells were detected in the latter group. 
Ly6GHigh and F4/80High cells described above were only found in the ischemic cortex, 
particularly in IL-10 KO mice, but were not detected in the blood of IL-10 KO or WT mice 
(not shown) suggesting that this phenotypic shift was induced by the local ischemic brain 
environment. 
 
IL-10 is important for the immunosuppressive function of regulatory T cells (Treg). For 
this reason we examined whether IL-10 deficiency could alter the expression of other T 
cell immunosuppressive molecules. Notably, the ischemic tissue of IL-10 KO mice showed 
a significantly higher expression of the T cell inhibitory molecule CTLA-4 mRNA at day 4 
post-ischemia compared to the WT ischemic tissue (Fig. 7B). In the spleen, similar 
percentages of Treg (CD3+CD4+CD25+Foxp3+) were detected in both genotypes 4 and 7 
days post-ischemia (Supplementary Fig. 5). The proportion of CD3+CD4+CD25+ cells that 
were CTLA-4 (CD152) positive tended to increase in the spleen of IL-10 KO mice, but 
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differences versus the WT were not statistically significant (Supplementary Fig. 5). 
However, the CTLA-4 mean fluorescence intensity (MFI) in the CD3+CD4+CD25+ cell 
population (Fig. 7D), was significantly higher in the spleen of IL-10 KO mice 4 and 7 days 
post-ischemia (two-way ANOVA by genotype and time showed a significant genotype 
effect, p<0.05) (Fig. 7E), suggesting up-regulation of CTLA-4 expression in the Treg 
population of IL-10 deficient mice. Altogether these findings support that in the absence 
of IL-10 compensatory alternative immunosuppressive mechanism are up-regulated after 
stroke. 
 
 
DISCUSSION 
 
The results of this study show that IL-10 deficiency exacerbates brain inflammation after 
pMCAO, especially at day 4 when IL-10 is expected to exert an action in the ischemic 
tissue due to the up-regulation of this cytokine and its receptor. Strategies increasing 
anti-inflammatory IL-10 in the brain are beneficial in experimental ischemia 12,13, and 
mice deficient in IL-10 showed more brain damage than WT mice after pMCAO 14. Here 
we found that IL-10 KO mice had slightly larger infarct volumes and worse neurological 
deficits than the WT mice during the first few days post-ischemia. However, these 
differences were attenuated at day 7, when in this experimental stroke model the extent 
of the lesion had markedly regressed 21,22. This finding supports that IL-10 is not required 
for the process of lesion involution.  
  
Notably, the increase in infarct volume in IL-10 KO mice found in our study was quite 
small and it was milder than that previously reported 14. These differences in scale might 
be attributable to the specific animal housing conditions. Exposure of IL-10 KO mice to 
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environmental pathogens when they were kept under conventional housing conditions 
triggered the development of apparent signs of colitis, while maintaining the animals in a 
pathogen-free environment prevented this effect, as previously reported 16. 
Development of colitis was associated with a worse stroke outcome, in agreement with 
the described worsening effect of systemic inflammation 20. Therefore, ongoing 
inflammatory pathology adds a confounding factor exaggerating the direct effects of IL-
10 deficiency in stroke.   
 
IL-10 expression was up-regulated in the ischemic tissue soon after pMCAO, suggesting 
the involvement of resident cells. The capacity of microglia to secrete IL-10 has been 
reported after exposure to several agents such as adenosine 26, extracellular ATP 27, or 
LPS 28. Several lines of evidence support beneficial functions for microglia in stroke 29, 30 
but it is unknown whether these effects are dependent on IL-10. Treatment of cultured 
microglia with recombinant IL-10 did not attenuate the inflammatory reaction triggered 
by insufficient oxygen supply, but it strongly suppressed cytokine induction after TLR-4 
activation. After brain ischemia, the initial inflammatory reaction can be secondarily 
aggravated by necrotic cell death, as it generates danger signals 31 that activate TLR-4, 
inducing further inflammation 8 and contributing to brain damage 32. Here, IL-10 
deficiency did not increase the local inflammatory reaction within the first hours 
following pMCAO, but it did 4 days later. This finding is in accordance with the 
exacerbated secondary inflammatory process seen in IL-10 KO mice after spinal cord 
compression injury 33 and in a model of brain bacterial infection 34.  
 
The neuroinflammatory reaction is a dynamic process and inflammation is also involved 
in tissue repair mechanisms that are modulated by the complex crosstalk between 
resident glia and infiltrated immune cells 35. Importantly, appropriate orchestration of 
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the inflammatory responses is critical to allow for lesion resolution. Reactive astrocytes 
can sense the presence of IL-10 since they showed strong expression of IL-10R at days 4 
and 7 post-ischemia. Therefore, astrocytes may play a role in controlling inflammatory 
and immune responses after stroke. Infiltrated macrophages participate through 
phagocytosis in the process of clearance of the injured tissue 36. In our experimental 
conditions, absence of IL-10 facilitated the presence in the ischemic tissue of myeloid 
cells (F4/80High cells) that are considered mature phagocytic cells. Accordingly, the 
ischemic tissue of IL-10 KO mice showed higher expression of galectin-3, a protein 
related to phagocytic activity, and greater up-regulation of the anti-inflammatory M2 
makers arginase-1 and YM-1, compared to the WT mice. Neutrophils also acquired a 
more mature phenotype in the brain of IL-10 KO mice by showing higher expression of 
Ly6G. Neutrophils with this phenotypic feature have been described in the context of 
tumours 37 and in bacterial infections 38, where they exert anti-inflammatory and 
immunosuppressive functions. Since leukocytes with these features were not detected in 
the circulation, it is likely that the specific local brain environment was the trigger of the 
phenotypic changes observed in myeloid cells in the ischemic IL-10 KO brain.  
 
Beneficial effects of Treg in brain ischemia are mediated by IL-10 39. Therefore, lack of IL-
10 could impair the immunosuppressive function of Treg. However, immunosuppressive 
functions can be promoted by alternative mechanisms, such as that mediated by the T 
cell inhibitory receptor CTLA-4 40, which after brain ischemia was more prominent in the 
IL-10 KO mice than in the WT.  
 
In summary, this study shows that IL-10 attenuates the local inflammatory reaction after 
brain ischemia as IL-10 deficiency transiently enhanced the expression of pro-
inflammatory cytokines and chemokines and slightly increased the size of the lesion and 
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worsened the neurological deficits. However, the study does not support a fundamental 
role for IL-10 in subsequent lesion involution, likely due to compensatory mechanisms 
able to control immune responses in the absence of IL-10. 
  
Supplementary information is available at the Journal of Cerebral Blood Flow & 
Metabolism website – www.nature.com/jcbfm 
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Titles and legends to figures 
 
Fig. 1 Ischemia up-regulates the expression of IL-10 and IL-10 receptor in WT mice. A) 
Expression of IL-10 mRNA progressively increases in brain tissue after pMCAO from 6 
hours (h) to 7 days (d). B) The extent of IL-10 mRNA expression correlates (linear 
regression analysis, p<0.03) with infarct volume that was measured by MRI (T2) in the 
same animals 6 hours following pMCAO. C) The concentration of soluble IL-10 in brain 
tissue increased after pMCAO. D) Increased expression of IL-10 receptor (IL-10R) is 
apparent from 4 days post-ischemia, but not within the first day. mRNA values are 
expressed as fold increase versus control non-ischemic brain tissue, and protein 
values are expressed as pg of IL-10 per mg of brain protein. E-H) Immunofluorescence 
staining of IL-10R (green) in the cortex of controls (E) and after pMCAO (F-H). E) IL-
10R immunoreaction (green) is not detected in the control cortex. Isolectin (red) 
staining shows resident microglia and blood vessels. F) Isolated IL-10R positive cells 
are detected in the subarachnoid space on the top of the ischemic cortex after 
pMCAO. G) IL-10R immunoreactive cells (green) are seen in superficial cortical layers 
from 4 days post-ischemia. These cells are rarely positive (arrow) for isolectin (red) 
and most of the IL-10R+ cells have morphology (arrowhead) compatible with that of 
reactive astrocytes. H) Double-staining with GFAP (red) shows that most IL-10R+ cells 
are astrocytes (arrow). The cell nuclei were stained with Hoechst (blue). Images in F, 
G and H correspond to days 1, 4 and 7 after pMCAO, respectively. Bar scale: 20 m. 
n=4-6 mice per group. * p<0.05, *** p<0.001.  
 
Fig. 2 IL-10 deficiency slightly increases infarct volume and neurological deficits. A) Brain 
infarction was longitudinally monitored by T2 MRI in the same mice at days 1, 4 and 7 
post-ischemia and a representative animal per group is shown. B) Infarct volume is 
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slightly larger in IL-10 KO mice (n=17) than in the WT (n=20) (two-way ANOVA by 
genotype and time; p<0.05 for genotype effect; p<0.001 for time effect). C) In an 
additional group of mice, MRI was followed by histology in the same mice. T2 maps of 
representative brain slices at day 7 after pMCAO are shown with their corresponding 
histological staining (cresyl violet). D) Infarct volume measured by MRI and by 
histological means in the same mice shows a good correlation (linear regression 
analysis, r2=0.8, p<0.001). E) The infarct volume measured by histological means is 
significantly smaller (p<0.001) than the corresponding MRI measures. However, with 
either method, genotype group differences at day 7 are not statistically significant. F) 
At day 1, the ratio of the volume of the ipsilateral to the contralateral hemisphere is 
above 1 due to edema. The effect is attenuated at day 4, while at day 7 the ipsilateral 
hemispheric volume is reduced. However hemispheric volume differences between 
WT and IL-10 KO mice are similar along time. D-F) Measure of the time to shake (D), 
contact (E) and remove (F) steps of the adhesion/removal tape test shows worse 
neurological deficits at day 3, as shown by a significant delay in the time to shake (D) 
and remove (F) for the contralateral (left) forepaw, but the worsening effects of IL-10 
deficiency are attenuated at day 7. Animals in panels (F-I) are the same as in (B) * 
p<0.05.  
 
Fig. 3 IL-10 deficiency does not exacerbate the inflammatory reaction 6 hours post-
ischemia. The mRNA expression for the stated molecules increases in both WT and IL-
10 KO ischemic brain tissue at 6 hours. Values are expressed as fold versus control 
WT. n=6 mice per group, * p<0.05, ** p<0.01.  
 
Fig. 4 In cultured microglia, IL-10 attenuates the inflammatory response to LPS but not 
that induced by exposure to ischemic conditions. Cultured microglia show selective 
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inflammatory responses after stimulation with either 3-hour anoxia (group ‘A’) or 
with 10 ng/mL LPS (group ‘LPS’). A-F) Cytokine mRNA expression was evaluated by 
qRT-PCR analysis 6 hours after initiation of the challenge. G-J) Cytokine concentration 
in the culture medium was measured also at 6 hours by ELISA assays. A, C, E, G, I) 
Treatment with recombinant murine IL-10 (10 ng/mL) does not attenuate the 
response to anoxia (group ‘A+IL-10’). B, D, F, H, J) However, IL-10 strongly prevents 
the inflammatory response to LPS (group ‘LPS+IL-10’). Values were obtained in three 
independent cultures. Symbol * refers to comparison versus control, and symbol & 
refers to comparison versus either anoxia or LPS. One symbol: p<0.05, two symbols: 
p<0.01, and three symbols: p<0001.  
 
Fig. 5 IL-10 deficiency exacerbates secondary inflammation at day 4 after pMCAO. Brain 
expression of cytokine and chemokine mRNA is significantly increased in IL-10 KO 
than in WT mice at day 4, with the exception of CX3CL1, which decreases in IL-10 KO 
mice. Values are expressed as fold versus control WT. n=6 mice per group, * p<0.05, 
** p<0.01, *** p<0.001. 
 
Fig. 6 Differences between WT and IL-10 KO mice in the brain inflammatory response are 
attenuated at day 7. Brain expression of most cytokine and chemokine mRNA is no 
longer significantly different between IL-10 KO and WT mice at day 7. n=6 mice per 
group. Values are expressed as fold versus control WT. * p<0.05, ** p<0.01, *** 
p<0.001. 
 
Fig. 7 Compensatory immunosuppressive mechanisms in IL-10 KO mice after ischemia. A) 
Ischemia increases the number of cells expressing F4/80+ (microglia/macrophages) to 
a similar extent in both genotypes at day 4. However, more F4/80High phagocytic cells 
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are seen in the brain of IL-10 KO than in WT mice. B) The ischemic tissue of IL-10 KO 
mice shows a higher up-regulation of the mRNA of galectin-3, Arginase-1, YM-1 and 
CTLA-4 (n=4-6 samples per time group). C) At day 4, the numbers of Ly6G+ cells 
(neutrophils) is similar in the ipsilateral cortex of IL-10 KO and WT mice, but higher 
numbers of Ly6GHigh neutrophils are seen in the ischemic cortex of the IL-10 KO mice. 
Flow cytometry diagrams shown in the right panels of (A) and (C) correspond to one 
representative sample out of n=5 independent samples per group. D) Representative 
dot plots of CTLA-4 expression (CD152) in splenocytes from WT mice and IL-10 KO 
mice 7 days after pMCAO. Single viable cells are plotted by CD152 versus CD4 
expression. E) Single viable splenocytes are subsequently gated on CD3+ CD4+ and 
CD25+ cells. CTLA-4 mean fluorescence intensity (MFI) in the latter cells is higher in IL-
10 KO mice than in WT mice. Two-way ANOVA by genotype and time. *p<0.05 and 
***p<0.001 versus ischemic tissue of WT mice. 
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